This article was originally published in The Gray Sheet
Executive SummaryHearing aid maker's initial public offering proceeds reach $53.9 mil. following the exercise of a 540,000-share overallotment option by underwriters Goldman Sachs, Deutsche Banc Alex. Brown and U.S. Bancorp Piper Jaffray. Completed May 9, the Salt Lake City firm's IPO included a total of 4.1 mil. shares at $14 each, including the overallotment shares (1"The Gray Sheet" May 8, p. 10)
You may also be interested in...
Companion diagnostics are needed increasingly by pharma companies to justify the safety and effectiveness of their products. With specific first-time EU regulation of these products within sight – and urgently needed – is there a risk of delays to these products being able to demonstrate compliance?
Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.